Barrera-Salas M, Morales-Hernández AE, Hernández-Osorio JJ, Hernández-Salcedo DR, Valencia-López R, Ramírez-Crescencio MA

Idioma: Español
Referencias bibliográficas: 30
Paginas: 696-704
Archivo PDF: 636.22 Kb.

RESUMEN

La inmunosenescencia se refiere a los cambios que se producen en el sistema inmunitario a causa del envejecimiento y que afectan la inmunidad innata y adaptativa. Estos cambios predisponen a padecer enfermedades infecciosas, cáncer, autoinmunidad y a respuestas escasas tras la administración de vacunas.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Romero Cabrera AJ, et al. Inmunosenescencia y fragilidad: una mirada actual. Med Int Méx 2013;29(6).

2. Bürkle, et al. Pathophysiology of ageing, longevity and age related diseases. Immun Ageing 2007;4:4.

3. Mitchell WA, Lang PO, Aspinall R. Tracing thymic output in older individuals. Clin Exp Immunol 2010;161:497- 503.

4. Qian F, Guo X, Wang X, et al. Reduced bioenergetics and toll-like receptor 1 function in human polymorphonuclear leukocytes in aging. Aging (Albany NY) 2014; 6:131-9.

5. Fülöp T, et al. The role of immunosenescence in the development of age-related diseases. Rev Inves Clin 2016;68:84-91.

6. Juthani-Mehta M, Guo X, Shaw AC, et al. Innate immune responses in the neutrophils of community dwelling and nursing home elders. J Aging Sci 2014;2.

7. Ongrádi J, Kövesdi V. Factors that may impact on immunosenescence: an appraisal. Immun Ageing 2010;7:7.

8. Ledesma-Heyer, Valdés-Escárcega, Ramos-Ostos. ¿Somos tan viejos como nuestros linfocitos? Inmunosenescencia. Rev Invest Med Sur Mex 2011;18(4): 168-173.

9. Saavedra H, García V. Inmunosenescencia: efectos de la edad sobre el sistema inmune. Revista Cubana de Hematol, Inmunol y Hemoter 2014;30(4):332-345.

10. Herrero C, Celada A. Inmunosenescencia. Inmunología 2000;19(2-3):75-80.

11. Licastro F, Grimaldi LME, Bonafe M, et al. Interleukin-6 gene alleles affect the risk of Alzheimer’s disease and levels of the cytokine in blood and brain. Neurobiol Aging 2003;24:921-6.

12. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93:190.

13. Hammarström L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000;120:225.

14. Gathmann B, Grimbacher B, Beauté J, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin Exp Immunol 2009;157(Suppl 1):3.

15. Gathmann B, Mahlaoui N, Ceredih, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014;134:116.

16. Romero Cabrera AJ, et al. Inmunosenescencia y fragilidad: una mirada actual. Med Int Méx 2013;29(6).

17. Bürkle, et al. Pathophysiology of ageing, longevity and age related diseases. Immun Ageing 2007;4:4.

18. Mitchell WA, Lang PO, Aspinall R. Tracing thymic output in older individuals. Clin Exp Immunol 2010;161:497- 503.

19. Qian F, Guo X, Wang X, et al. Reduced bioenergetics and toll-like receptor 1 function in human polymorphonuclear leukocytes in aging. Aging (Albany NY) 2014; 6:131-9.

20. Fülöp T, et al. The role of immunosenescence in the development of age-related diseases. Rev Inves Clin 2016;68:84-91.

21. Juthani-Mehta M, Guo X, Shaw AC, et al. Innate immune responses in the neutrophils of community dwelling and nursing home elders. J Aging Sci 2014;2.

22. Ongrádi J, Kövesdi V. Factors that may impact on immunosenescence: an appraisal. Immun Ageing 2010;7:7.

23. Ledesma-Heyer, Valdés-Escárcega, Ramos-Ostos. ¿Somos tan viejos como nuestros linfocitos? Inmunosenescencia. Rev Invest Med Sur Mex 2011;18(4): 168-173.

24. Saavedra H, García V. Inmunosenescencia: efectos de la edad sobre el sistema inmune. Revista Cubana de Hematol, Inmunol y Hemoter 2014;30(4):332-345.

25. Herrero C, Celada A. Inmunosenescencia. Inmunología 2000;19(2-3):75-80.

26. Licastro F, Grimaldi LME, Bonafe M, et al. Interleukin-6 gene alleles affect the risk of Alzheimer’s disease and levels of the cytokine in blood and brain. Neurobiol Aging 2003;24:921-6.

27. Conley ME, Notarangelo LD, Etzioni A. Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 1999;93:190.

28. Hammarström L, Vorechovsky I, Webster D. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 2000;120:225.

29. Gathmann B, Grimbacher B, Beauté J, et al. The European internet-based patient and research database for primary immunodeficiencies: results 2006-2008. Clin Exp Immunol 2009;157(Suppl 1):3.

30. Gathmann B, Mahlaoui N, Ceredih, et al. Clinical picture and treatment of 2212 patients with common variable immunodeficiency. J Allergy Clin Immunol 2014;134:116.